Next Generation Gene Therapeutics

About:

Next Generation Gene Therapeutics is a healthcare company that engages in the research and development of gene therapy.

Top Investors: Northern Light Venture Capital, Shanghai Biomedical Industrial Equity Investment Fund, DT Capital Partners, BioVenture, WeDo Capital Management

Description:

Next Generation Gene Therapeutics is a healthcare company that engages in the research and development of gene therapy. Its unique propriety technology of "one target and two bullets" can provide effective treatment for a variety of genetic diseases that currently have few therapeutic methods in the world. NGGT was founded in March 2020 by senior scientists and entrepreneurs in the field of gene therapy. It is committed to becoming the world's leading gene therapy company with international influence. The company has successful experience in the whole industry chain, concerning the early development of gene therapy products, the large-scale production of viral vectors, the construction of quality standards, international multi-center clinical research, and the application for the marketing of gene therapy products.